ASCIA anaphylaxis and allergy e-training courses were completed by a total of 124,227 course participants in 2024, a 32% increase compared with 94,193 in 2023, including:

• 87,580 school anaphylaxis course completions - an increase of 19% compared to 74,201 course completions in 2023*
• 14,318 children's education/care (CEC) anaphylaxis course completions - an increase of 57% compared to 9,133 course completions in 2023
• 14,011 health professional anaphylaxis and allergy course completions - an increase of 150% compared to 5,589 course completions in 2023**
• 4,621 schools, CEC and community anaphylaxis refresher course completions - an increase of 30% compared to 3,568 course completions in 2023 
• 2,816 first aid (community) anaphylaxis course completions - an increase of 12% compared to 2,514 course completions in 2023 

*Course completions in 2024 are in addition to completions of ASCIA anaphylaxis e-training courses licenced to be on NSW, QLD and WA Education Departments for use on their LMS platforms. 

**The significant increase in course completions is largely due to the increased promotion of the courses by ASCIA. The increase suggests that there is a high need for health professionals to have access to this form of training, reflecting the rising prevalence of allergic disease in Australia and New Zealand. 

The mandatory evaluation reports for 2024 indicate that ASCIA anaphylaxis and allergy courses for health professionals were completed by:

• 5,622 nurses (including nurse practitioners and nurse assistants)
• 3,132 pharmacists
• 543 pharmacy assistants
• 259 general practitioners
• 108 dietitians
• 97 paediatricians
• 95 medical/health educators
• 81 paramedics
• 3,278 other health professionals

In 2024, ASCIA courses were also completed by 796 students who are not yet working as health professionals. 

ASCIA anaphylaxis e-training for health professional evaluations in 2024 included 2,973 (30%) very positive responses, and these are examples from the report:

“There is no need to improve the course as it provided the information that is needed and is delivered in a great way.”

“The course is great and informative and useful to nursing practice.”

“Great, so accessible and user friendly, good job!”

“It was good, I like that it was broken into modules and that each topic was on a new page.”

“Each module was perfectly presented.”

“Everything is well discussed. No improvement needed.”

“I am satisfied with this course, and it has met my learning needs.”

“I believe everything is perfect as it is! The course content is comprehensive, the delivery is engaging, and the support provided is excellent. I appreciate the effort that has gone into making this course successful.”

“It had all the information that one should know about allergy and anaphylaxis covering everything write from its symptoms till it's treatment and prevention.“

ASCIA anaphylaxis e-training for schools evaluations in 2024 included 23,093, (61%) very positive responses, and these are examples from the report:  

“I believe the course is well designed, easy to understand for a beginner.”

“This is a very useful course that is delivered in a simple format which covers all required information and knowledge needed by someone who might be in a situation of an allergy reaction / anaphylaxis. Thank you making this course accessible for all.”

“It was a good course and great that it didn’t need to be completed in one sitting.”

“It was clear and a great review of my current knowledge with the opportunity to refresh my understanding.”

“Everything about the course was done well, I see no need for improvement.”

“Easy to understand through succinct and relevant information provided - thank you.”

“Happy with course, very informative.”

“No changes needed, very informative and engaging course.”

“Honestly it was easy to grasp information, that was again repeated after answering. I feel I have all the information I need.”

ASCIA anaphylaxis e-training for children’s education and care (CEC) services evaluations in 2024 included 5351 (64%) very positive responses, and here are examples from the report:

“I’m satisfied with this course.”

“Nothing to improve, I agree with everything already provided.”

“Nothing to say, very good course.”

“Very impressed on the delivery of this course.”

This news item was issued on 19 June 2025 by Jill Smith, CEO of ASCIA, the peak professional body for clinical immunology and allergy in Australia and New Zealand.